| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Compass Therapeutics, Inc. (CMPX) has 12 insiders with recent SEC Form 4 filings, including 1 buy and 0 sells. CMPX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 6.60M | $13.34M | - | |
| Other | 1.00M | $2.02M | - | |
| Other | 1.00M | $2.02M | - | |
| CFO | 525.0K | $1.06M | - | |
| Other | 397.5K | $803.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 19, 2020 | Sunderland Julie | Director | Buy | 289,118 | $5.00 | $1,445,590.00 | +13.1% |